Lanean...
MicroRNAs as emerging biomarkers and therapeutic targets for pancreatic cancer
Despite tremendous efforts from scientists and clinicians worldwide, pancreatic adenocarcinoma (PDAC) remains a deadly disease due to the lack of early diagnostic tools and reliable therapeutic approaches. Consequently, a majority of patients (80%) display an advanced disease that results in a low r...
Gorde:
| Egile Nagusiak: | , , , , , , , , , , , , , , , , |
|---|---|
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
Baishideng Publishing Group Inc
2014
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4145758/ https://ncbi.nlm.nih.gov/pubmed/25170204 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3748/wjg.v20.i32.11199 |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|